Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Higher IGF-1 levels in hair follicles link to better finasteride results for hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Compound 15a was effective in inhibiting 5α-reductase.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

New progesterone-based compounds can block male hormones.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.